Loading
Latest filing published 15 Jul 2026 for IX BIOPHARMA LTD., €41k.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Albert Ho Shing Tung on record concern IX Biopharma Ltd. The record holds 8 filings, for trades running from 2 July 2021 to 14 July 2026.
No open-market sale appears; the market trades are 5 purchases worth €170k. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2026 alone, the filings show 1 purchase and no sales.
Half of the purchases are above €42k and half below.
On 15 July 2026 came the latest disclosure, an open-market purchase for €41k in IX Biopharma Ltd. Typically, a trade is published a median of 3 days after it takes place. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SGX and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations